Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / Neutrophils
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Monocyte differential count
|
HET
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.311
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD25+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.693
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / Eosinophils
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Mean platelet volume
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.267
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Eosinophil differential count
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.553
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
Haematology / Mean cell volume
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
2.10×10-05
|
Successful |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
Haematology / Mean corpuscular haemoglobin
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.138
|
Successful |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
Haematology / Mean cell haemoglobin concentration
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000258
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NKT Subsets (Q3)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
Haematology / Platelets count
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.965
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD25+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NK Subsets (Q1)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Mean cell volume
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.396
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NKT cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
FACs Analysis / T cell CD8+ percentage
|
HET
|
f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.150
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Basophil cell count
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.786
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / B1B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
FACs Analysis / T cell CD4+ percentage
|
HET
|
f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.182
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Red blood cell count
|
HET
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.291
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / cDCs CD11b Type
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Hematocrit
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.675
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NK Subsets (Q3)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD25- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NKT Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Neutrophil cell count
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.593
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / T Subset
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Large Unstained Cell (LUC) count
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.447
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Lymphocyte cell count
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.464
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Platelet count
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.560
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / Monocytes
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Monocyte cell count
|
HET
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.282
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / T Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD25- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NK Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.746
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD25- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Large Unstained Cell (LUC) differential count
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.362
|
Successful |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
FACs Analysis / NK cell percentage
|
HET
|
f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.511
|
Successful |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
FACs Analysis / Granulocyte Gr1+ percentage
|
HET
|
f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
|
Successful |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
FACs Analysis / Monocyte gate
|
HET
|
f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.437
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
FACs Analysis / CD25+ percentage of CD4+ T cells
|
HET
|
f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.621
|
Successful |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
FACs Analysis / T cell CD3+ percentage
|
HET
|
f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.861
|
Successful |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
FACs Analysis / Mature B cells IgD+ percentage
|
HET
|
f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.528
|
Successful |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
FACs Analysis / B cell CD19+ percentage
|
HET
|
f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00782
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Eosinophil cell count
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.247
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / cDCs
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Hemoglobin
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.820
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Basophil differential count
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.900
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NK Subsets (Q2)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / MZB (CD21/35 high)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
Haematology / White blood cell count
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.894
|
Successful |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
Haematology / Red blood cell count
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.166
|
Successful |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
Haematology / Haemoglobin
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.235
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NK cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1a(EUCOMM)Hmgu
|
ICS
|
Haematology / Haematocrit
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.122
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / B2B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NK Subsets (Q4)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Neutrophil differential count
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.230
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Red blood cell distribution width
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.366
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD25+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / NKT Subsets (Q1)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD25+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Clinical Chemistry / Glycosilated hemoglobin A1c (HbA1c)
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0162
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / T cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / Lymphocyte differential count
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.622
|
Successful |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Mat2atm1b(EUCOMM)Hmgu
|
RBRC
|
Hematology / White blood cell count
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.524
|
Successful |